Bivalirudin versus heparin in patients undergoing percutaneous transcatheter aortic valve interventions: A systematic review and meta ‐analysis
ConclusionsIn patient undergoing aortic valve interventions, no difference was seen between the use of bivalirudin and heparin as the procedural anticoagulant agent, except for a significant lower myocardial infarction events when bivalirudin was used. Further large randomized trials are needed to confirm current results.
Source: Journal of Interventional Cardiology - Category: Cardiology Authors: Pedro A. Villablanca, Rasha Al ‐Bawardy, Divyanshu Mohananey, Carola Maraboto, Michael Weinreich, Tanush Gupta, David F. Briceno, Harish Ramakrishna Tags: ORIGINAL INVESTIGATION Source Type: research
More News: Angiomax | Bleeding | Blood Transusion | Cardiology | Cardiovascular | Databases & Libraries | Heart | Heart Attack | Stroke | Study | Urology & Nephrology